ReviewFrontiers in pediatrics2026
Advances in laboratory diagnosis of neonatal hyperbilirubinemia and peculiarities in plateau regions: a review of evidence.
Review in Frontiers in pediatrics, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
High-altitude neonatal hyperbilirubinemia refers to a common condition in newborns residing at elevations of 2,500 meters or higher. This condition arises from the combination of high-altitude environmental factors-such as hypoxia and low atmospheric pressure-with physiological characteristics specific to newborns, including immature bilirubin metabolism and increased red blood cell destruction. These factors collectively lead to abnormally elevated serum bilirubin levels. However, studies on the prevalence and associated factors of neonatal hyperbilirubinemia have remained controversial due to influences from cultural, demographic, geographic, climatic, and clinical conditions. The World Health Organization recommends a one-day hospital stay after uncomplicated delivery, jaundice assessment prior to discharge, and screening for hyperbilirubinemia on the third and seventh days after birth. Due to constraints such as the harsh environment of plateau regions, regional economic deprivation, insufficient investment in medical resources, and risks associated with genetic variations among populations, implementing these recommendations proves particularly challenging in China, especially in high-altitude ethnic minority areas. Therefore, medical laboratory technology plays a pivotal role in the early screening, diagnosis, and treatment efficacy assessment of neonatal hyperbilirubinemia in high-altitude regions. This systematic review summarizes recent advances in the epidemiological characteristics, etiological mechanisms, diagnostic strategies, and therapeutic interventions for neonatal hyperbilirubinemia in high-altitude regions. It also examines the application value of rapid detection technologies and specific intervention strategies in plateau areas. Finally, it outlines future research directions, providing evidence-based guidance and practical recommendations for clinical practitioners.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.